FAIRFAX, Va. – General Dynamics Information Technology, a business unit of General Dynamics (NYSE: GD), has been selected by the Army Contracting Command as one of the awardees for the Omnibus III contract to provide medical research support services. Through this contract, General Dynamics will provide personnel, materials, equipment, limited facilities, science and technology that will sustain medical research efforts.
The Navy Medicine Research contract is a five-year, indefinite delivery, indefinite quantity, multiple-award contract with a total potential value of $497 million to all awardees if all options are exercised.
In addition to providing the support to sustain medical research efforts, General Dynamics will work with Navy Medicine teams to address a range of processes including procedures for basic university research, vaccine development, clinical trials and U.S. Food and Drug Administration (FDA) investigational new drug application processing.
“General Dynamics will provide Navy Medicine Research exceptional support to enable their enterprise-wide research and development efforts,” said Marcus Collier, senior vice president of the Health and Civilian Solutions Division for General Dynamics Information Technology. “With over 21 years of experience supporting Military Health System organizations, our unique insight and knowledge of our customer’s requirements will allow us to be a trusted partner to the U.S. Navy and support their mission by providing high-quality health care for military personnel and their families.”
The U.S. Navy Bureau of Medicine and Surgery (BUMED) serves as headquarters command for Navy Medicine, which provides health care services to beneficiaries in both wartime and peacetime. Navy Medicine personnel deploy to care for Sailors and Marines abroad as well as provide healthcare services for uniformed services’ family members and retirees at military facilities worldwide.
For more information about General Dynamics Information Technology, please visit www.gdit.com.
More news and articles can be found on Facebook and Twitter.